These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10751624)

  • 1. Subchronic administration of phenobarbital alters the mutation spectrum of lacI in the livers of Big Blue transgenic mice.
    Shane BS; Smith-Dunn DL; deBoer JG; Glickman BW; Cunningham ML
    Mutat Res; 2000 Mar; 448(1):69-80. PubMed ID: 10751624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxazepam is mutagenic in vivo in Big Blue transgenic mice.
    Shane BS; deBoer JG; Glickman BW; Cunningham ML
    Carcinogenesis; 1999 Jul; 20(7):1315-21. PubMed ID: 10383906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure.
    Sisk SC; Pluta LJ; Meyer KG; Wong BC; Recio L
    Mutat Res; 1997 Jul; 391(3):153-64. PubMed ID: 9268040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant frequencies and mutation spectra of dimethylnitrosamine (DMN) at the lacI and cII loci in the livers of Big Blue transgenic mice.
    Shane BS; Smith-Dunn DL; de Boer JG; Glickman BW; Cunningham ML
    Mutat Res; 2000 Sep; 452(2):197-210. PubMed ID: 11024479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the mutant frequencies and mutation spectra of three non-genotoxic carcinogens, oxazepam, phenobarbital, and Wyeth 14,643, at the lambdacII locus in Big Blue transgenic mice.
    Singh VK; Ganesh L; Cunningham ML; Shane BS
    Biochem Pharmacol; 2001 Sep; 62(6):685-92. PubMed ID: 11551513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure.
    Walker VE; Sisk SC; Upton PB; Wong BA; Recio L
    Mutat Res; 1997 Aug; 392(3):211-22. PubMed ID: 9294020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacI transgenic mice (Big Blue): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure.
    Recio L; Meyer KG; Pluta LJ; Moss OR; Saranko CJ
    Environ Mol Mutagen; 1996; 28(4):424-9. PubMed ID: 8991073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B1.
    Dycaico MJ; Stuart GR; Tobal GM; de Boer JG; Glickman BW; Provost GS
    Carcinogenesis; 1996 Nov; 17(11):2347-56. PubMed ID: 8968048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
    Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
    Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene.
    Saranko CJ; Meyer KG; Pluta LJ; Henderson RF; Recio L
    Mutat Res; 2001 Jan; 473(1):37-49. PubMed ID: 11166025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
    Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
    Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy.
    Shane BS; Lockhart AM; Winston GW; Tindall KR
    Mutat Res; 1997 Jun; 377(1):1-11. PubMed ID: 9219573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
    Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
    Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
    Zimmer DM; Harbach PR; Mattes WB; Aaron CS
    Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA adduct level induced by 2-amino-3,4-dimethylimidazo[4,5-f]-quinoline in Big Blue mice does not correlate with mutagenicity.
    Ochiai M; Ishida K; Ushijima T; Suzuki T; Sofuni T; Sugimura T; Nagao M
    Mutagenesis; 1998 Jul; 13(4):381-4. PubMed ID: 9717175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of mutations in kidney, stomach, and liver from lacI transgenic mice recovered after treatment with tris(2,3-dibromopropyl)phosphate.
    de Boer JG; Mirsalis JC; Provost GS; Tindall KR; Glickman BW
    Environ Mol Mutagen; 1996; 28(4):418-23. PubMed ID: 8991072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen induces G:C-->T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5'-CpG-3' dinucleotide sequences as found in the lacI transgene.
    Davies R; Gant TW; Smith LL; Styles JA
    Carcinogenesis; 1999 Jul; 20(7):1351-6. PubMed ID: 10383911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo mutagenicity and mutational spectrum at the lacI transgene recovered from the spleens of B6C3F1 lacI transgenic mice following a 4-week inhalation exposure to 1,3-butadiene.
    Recio L; Pluta LJ; Meyer KG
    Mutat Res; 1998 Jun; 401(1-2):99-110. PubMed ID: 9639685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice.
    Suzuki T; Itoh T; Hayashi M; Nishikawa Y; Ikezaki S; Furukawa F; Takahashi M; Sofuni T
    Environ Mol Mutagen; 1996; 28(4):348-53. PubMed ID: 8991063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.